Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$22.55
+0.20%
Mkt Cap $3.60B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (13 analysts)
$21.25
Range $20.00 – $22.00
Implied Upside
-5.8%
Consensus $21.25 vs current $22.55